RNA expression patterns are associated with pancreatic cancer patient survival time.
A 19-transcript model can predict patient survival time in multiple cohorts.
A subset of survival transcripts is associated with gemcitabine response in vitro.
Reduced expression of ANGPTL4 impairs growth of a gemcitabine resistant cell line.